{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:05:40Z","timestamp":1790111140302,"version":"4.0.1"},"reference-count":65,"publisher":"American Chemical Society (ACS)","issue":"37","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00HL163805"],"award-info":[{"award-number":["R00HL163805"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY001765"],"award-info":[{"award-number":["EY001765"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD103124"],"award-info":[{"award-number":["R01HD103124"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD108905"],"award-info":[{"award-number":["R01HD108905"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021974","name":"Maryland Department of Commerce","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100021974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Solve GNE Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Active targeting can improve the efficacy of mRNA therapeutics, but ligand-mediated targeting with lipid nanoparticles (LNPs) remains challenging. Here, we studied the impact of polyethylene glycol (PEG)-lipid composition and triantennary N-acetylgalactosamine (TriGalNAc)-modification on the hepatic delivery efficiency of mRNA-LNPs. Incorporating TriGalNAc-lipid into LNPs containing dimyristoyl glycerol (DMG)-PEG2000 or distearoylphosphatidylethanolamine (DSPE)-PEG2000, excipients used in FDA-approved RNA-LNPs or liposomes, did not further improve hepatic mRNA delivery. We discovered that incorporating TriGalNAc-lipid into LNPs containing DSPE-PEG350 increased hepatic luciferase expression 4\u20136-fold over TriGalNAc-conjugated or unconjugated DMG-PEG2000 LNPs, and 60-fold over TriGalNAc-conjugated or unconjugated DSPE-PEG2000 LNPs in vivo. Despite its relatively low molecular weight PEG, unconjugated DSPE-PEG350 LNP showed moderately extended blood circulation but only moderately reduced cellular uptake in vitro, potentially providing a balanced platform for adding TriGalNAc ligands and improving the overall hepatic delivery efficiency in vivo. The pairing of TriGalNAc-lipid and DSPE-PEG350 in LNPs containing adenine base editor RNAs against PCSK9 lowered plasma cholesterol in wild-type mice, while conventional DMG-PEG2000 LNP was ineffective at the same dose. This study highlights the importance of redesigning the LNP surface to potentiate ligand-mediated active targeting to the liver.<\/jats:p>","DOI":"10.1021\/acsnano.6c10855","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:01:48Z","timestamp":1788850908000},"page":"25642-25659","source":"Crossref","is-referenced-by-count":0,"title":["Boosting Ligand-Mediated\nHepatic mRNA Delivery and\nGene Editing Through Coordinated Pairing of Polyethylene Glycol-Modified\nLipids"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-233X","authenticated-orcid":true,"given":"Saed","family":"Abbasi","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Bockley","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dohr","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davell M.","family":"Carter","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Berlinicke","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4329-3734","authenticated-orcid":true,"given":"Xizhen","family":"Lian","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Viskadourou","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Burke","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21205"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Newby","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21205"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University School of Medicine , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]},{"name":"Johns Hopkins University , , , ,","place":["Baltimore, Maryland, United States, 21231"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"11","key":"2026092216092271100_cit1","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","article-title":"In vivo somatic cell base editing and prime editing","volume":"29","author":"Newby","year":"2021","journal-title":"Mol. Ther."},{"issue":"1","key":"2026092216092271100_cit2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden\nof liver\ndiseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"22","key":"2026092216092271100_cit3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMe2410543","article-title":"Combination\nTherapy for Chronic HBV Infection","volume":"391","author":"Janssen","year":"2024","journal-title":"N. Engl.\nJ. Med."},{"issue":"3","key":"2026092216092271100_cit4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/hep.32441","article-title":"mRNA and gene\nediting: Late breaking therapies in liver diseases","volume":"76","author":"Zabaleta","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"2026092216092271100_cit5","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking\nthe promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"2026092216092271100_cit6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles\nfor mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"5","key":"2026092216092271100_cit7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/pharmaceutics13050644","article-title":"Multifunctional Immunoadjuvants\nfor Use in Minimalist\nNucleic Acid Vaccines","volume":"13","author":"Abbasi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"2026092216092271100_cit8","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of Polyethylene\nGlycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics\nof siRNA Lipid Nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther.--Nucleic\nAcids"},{"issue":"52","key":"2026092216092271100_cit9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","article-title":"On the\nmechanism of tissue-specific\nmRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"2026092216092271100_cit10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing\nfor Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"08.20","key":"2026092216092271100_cit11","doi-asserted-by":"publisher","first-page":"457104","DOI":"10.1101\/2021.08.20.457104","article-title":"Time evolution\nof PEG-shedding and serum protein coronation determines the cell uptake\nkinetics and delivery of lipid nanoparticle formulated mRNA","volume":"2021","author":"Gallud","year":"2021","journal-title":"bioRxiv"},{"issue":"10","key":"2026092216092271100_cit12","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity\nof lipid nanoparticles and its impact on the efficacy of mRNA vaccines\nand therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"2026092216092271100_cit13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.ymthe.2024.03.022","article-title":"Carrier-free\nmRNA vaccine induces robust immunity against\nSARS-CoV-2 in mice and non-human primates without systemic reactogenicity","volume":"32","author":"Abbasi","year":"2024","journal-title":"Mol. Ther."},{"key":"2026092216092271100_cit14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/eurjpc\/zwaf123","article-title":"Challenges in Achieving\nLDL Cholesterol\nTargets and Novel Approaches to Lipid Lowering","volume":"32","author":"Malick","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"12","key":"2026092216092271100_cit15","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1161\/ATVBAHA.121.316290","article-title":"N-Acetyl\nGalactosamine Targeting:\nPaving the Way for Clinical Application of Nucleotide Medicines in\nCardiovascular Diseases","volume":"41","author":"Biessen","year":"2021","journal-title":"Arterioscler., Thromb.,\nVasc. Biol."},{"key":"2026092216092271100_cit16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","article-title":"Different\nkinetics for the hepatic uptake of lipid nanoparticles between the\napolipoprotein E\/low density lipoprotein receptor and the N-acetyl-d-galactosamine\/asialoglycoprotein\nreceptor pathway","volume":"322","author":"Sato","year":"2020","journal-title":"J. Controlled Release"},{"issue":"40","key":"2026092216092271100_cit17","doi-asserted-by":"publisher","first-page":"37577","DOI":"10.1074\/jbc.M101786200","article-title":"Determination of\nthe upper size limit for uptake and processing of ligands by the asialoglycoprotein\nreceptor on hepatocytes in vitro and in vivo","volume":"276","author":"Rensen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026092216092271100_cit18","doi-asserted-by":"publisher","first-page":"1490003","DOI":"10.3389\/fimmu.2024.1490003","article-title":"Enhancing cell-mediated immunity through dendritic cell activation:\nthe role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating\nSR717","volume":"15","author":"Gong","year":"2024","journal-title":"Front. Immunol."},{"issue":"21","key":"2026092216092271100_cit19","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1021\/jacs.8b01551","article-title":"Receptor-Mediated Delivery of CRISPR-Cas9\nEndonuclease for Cell-Type-Specific Gene Editing","volume":"140","author":"Rouet","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"32","key":"2026092216092271100_cit20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"European Atherosclerosis Society Consensus\nPanel on Familial, H., Homozygous familial hypercholesterolaemia:\nnew insights and guidance for clinicians to improve detection and\nclinical management. A position paper from the Consensus Panel on\nFamilial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"2026092216092271100_cit21","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-Lipid\nnanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR\nbase editing therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat. Commun."},{"issue":"18","key":"2026092216092271100_cit22","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1039\/D5NR00433K","article-title":"PEGylated\nlipid screening, composition optimization, and structure-activity\nrelationship determination for lipid nanoparticle-mediated mRNA delivery","volume":"17","author":"Liu","year":"2025","journal-title":"Nanoscale"},{"issue":"1","key":"2026092216092271100_cit23","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA\ndelivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"2026092216092271100_cit24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","article-title":"PEGylated nanoparticles\nfor biological\nand pharmaceutical applications","volume":"55","author":"Otsuka","year":"2003","journal-title":"Adv. Drug Delivery\nRev."},{"issue":"Pt A","key":"2026092216092271100_cit25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a\nstrategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"issue":"6","key":"2026092216092271100_cit26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol\ndilemma: advantage\nand disadvantage of PEGylation of liposomes for systemic genes and\nnucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm.\nBull."},{"key":"2026092216092271100_cit27","doi-asserted-by":"publisher","first-page":"114726","DOI":"10.1016\/j.ejpb.2025.114726","article-title":"From in vitro\nto in vivo: The Dominant role of PEG-Lipids in LNP performance","volume":"212","author":"Borah","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"2026092216092271100_cit28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcph.1553","article-title":"Pharmacokinetics\nof Patisiran, the\nFirst Approved RNA Interference Therapy in Patients With Hereditary\nTransthyretin-Mediated Amyloidosis","volume":"60","author":"Zhang","year":"2020","journal-title":"J. Clin.\nPharmacol."},{"key":"2026092216092271100_cit29","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19\nvaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"2026092216092271100_cit30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2023.01.007","article-title":"Liver cancer cells as the model for\ndeveloping liver-targeted\nRNAi therapeutics","volume":"644","author":"Hou","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"2026092216092271100_cit31","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A Direct Comparison\nof in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds\nof Nanoparticles Reveals a Weak Correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"issue":"14","key":"2026092216092271100_cit32","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block Copolymer Micelles\nin Nanomedicine Applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem. Rev."},{"issue":"13","key":"2026092216092271100_cit33","doi-asserted-by":"publisher","first-page":"2070101","DOI":"10.1002\/adma.202070101","article-title":"Ligand-Installed\nNanocarriers: Ligand-Installed\nNanocarriers toward Precision Therapy (Adv. Mater. 13\/2020)","volume":"32","author":"Mi","year":"2020","journal-title":"Adv. Mater."},{"issue":"3","key":"2026092216092271100_cit34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the biodistribution and\nclearance of nanomedicines","volume":"2","author":"Cabral","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"issue":"9","key":"2026092216092271100_cit35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation\ntriggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"2026092216092271100_cit36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting\n(SORT) lipid nanoparticles (LNPs) using multiple technical methods\nfor tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"issue":"7607","key":"2026092216092271100_cit37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery\nto dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"8","key":"2026092216092271100_cit38","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/acsabm.6c00050","article-title":"Formulation-Driven\nControl of mRNA Polyplex Physicochemical Properties Enables Spleen-Targeted\nSystemic Delivery","volume":"9","author":"Hori","year":"2026","journal-title":"ACS Appl. Bio Mater."},{"issue":"40","key":"2026092216092271100_cit39","doi-asserted-by":"publisher","first-page":"35675","DOI":"10.1021\/acsnano.5c11552","article-title":"Flower-Shaped\nLipid Nanoparticles Evade Apolipoprotein E-Mediated Liver Tropism\nfor Safe and Enhanced Cytokine-Based Cancer Immunotherapy","volume":"19","author":"Qi","year":"2025","journal-title":"ACS Nano"},{"key":"2026092216092271100_cit40","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jconrel.2024.11.007","article-title":"Characterization of mRNA-LNP structural features and mechanisms for\nenhanced mRNA vaccine immunogenicity","volume":"376","author":"Wu","year":"2024","journal-title":"J. Controlled\nRelease"},{"issue":"1","key":"2026092216092271100_cit41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymthe.2023.12.001","article-title":"First in vivo\nbase-editing trial shows promise","volume":"32","author":"Han","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"2026092216092271100_cit42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine\nbase editing of the brain, liver,\nretina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"2026092216092271100_cit43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for\nefficient in vivo\ndelivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"7859","key":"2026092216092271100_cit44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR\nbase editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"issue":"12","key":"2026092216092271100_cit45","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41569-021-00634-0","article-title":"PCSK9-targeted therapies: present\nand future approaches","volume":"18","author":"Rifai","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"2026092216092271100_cit46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tips.2018.06.001","article-title":"Novel Therapeutic\nTargets for Managing Dyslipidemia","volume":"39","author":"Sathiyakumar","year":"2018","journal-title":"Trends Pharmacol.\nSci."},{"issue":"8","key":"2026092216092271100_cit47","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine\nbase editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"2026092216092271100_cit48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics\nwith endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"1","key":"2026092216092271100_cit49","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated\nnanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat. Commun."},{"key":"2026092216092271100_cit50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","article-title":"Lipid nanoparticle mRNA systems containing\nhigh levels\nof sphingomyelin engender higher protein expression in hepatic and\nextra-hepatic tissues","volume":"30","author":"Chander","year":"2023","journal-title":"Mol. Ther. Methods Clin.\nDev."},{"issue":"26","key":"2026092216092271100_cit51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb8133","article-title":"Transient stealth coating\nof liver sinusoidal wall\nby anchoring two-armed PEG for retargeting nanomedicines","volume":"6","author":"Dirisala","year":"2020","journal-title":"Sci. Adv."},{"key":"2026092216092271100_cit52","doi-asserted-by":"publisher","first-page":"6c08403","DOI":"10.1021\/acsnano.6c08403","article-title":"2-arm-PEG-Oligocations Transiently\nShield the Liver Sinusoids to Mitigate Off-Target Hepatic Expression\nof mRNA Lipid Nanoparticles","author":"Dirisala","year":"2026","journal-title":"ACS Nano"},{"key":"2026092216092271100_cit53","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41551-025-01534-1","article-title":"Steric stabilization-independent\nstealth cloak enables nanoreactors-mediated starvation therapy against\nrefractory cancer","volume":"10","author":"Li","year":"2026","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"2026092216092271100_cit54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/mt.2012.256","article-title":"Therapeutic assessment of cytochrome\nC for the prevention\nof obesity through endothelial cell-targeted nanoparticulate system","volume":"21","author":"Hossen","year":"2013","journal-title":"Mol. Ther."},{"issue":"24","key":"2026092216092271100_cit55","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for\ntargeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"issue":"4","key":"2026092216092271100_cit56","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/nn305663e","article-title":"A systematic analysis\nof peptide linker length and liposomal polyethylene glycol coating\non cellular uptake of peptide-targeted liposomes","volume":"7","author":"Stefanick","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"2026092216092271100_cit57","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1038\/s41467-021-26926-0","article-title":"A novel mechanism for the loss of\nmRNA activity in lipid nanoparticle\ndelivery systems","volume":"12","author":"Packer","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"2026092216092271100_cit58","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization\nand structural properties\nof mRNA lipid nanoparticles influence expression in intramuscular\nand intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"key":"2026092216092271100_cit59","doi-asserted-by":"publisher","first-page":"0017","DOI":"10.34133\/bmr.0017","article-title":"Development\nof Lipid Nanoparticle Formulation for the\nRepeated Administration of mRNA Therapeutics","volume":"28","author":"Lee","year":"2024","journal-title":"Biomater. Res."},{"issue":"1","key":"2026092216092271100_cit60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42004-020-00369-y","article-title":"Structure\nof an anti-PEG antibody\nreveals an open ring that captures highly flexible PEG polymers","volume":"3","author":"Huckaby","year":"2020","journal-title":"Commun. Chem."},{"issue":"9","key":"2026092216092271100_cit61","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene\nGlycol Immunogenicity:\nTheoretical, Clinical, and Practical Aspects of Anti-Polyethylene\nGlycol Antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"3","key":"2026092216092271100_cit62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41565-025-02108-7","article-title":"Spatiotemporal\ntargeting\nof messenger RNA lipid nanoparticles to the endometrium for the treatment\nof reproductive disorders","volume":"21","author":"Abbasi","year":"2026","journal-title":"Nat. Nanotechnol."},{"key":"2026092216092271100_cit63","article-title":"Committee for\nthe Update of the Guide\nfor the Care and Use of Laboratory Animals","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Academies Press.","year":"1986"},{"issue":"1","key":"2026092216092271100_cit64","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk2855","article-title":"High-throughput and high-content bioassay enables tuning\nof polyester nanoparticles for cellular uptake, endosomal escape,\nand systemic in vivo delivery of mRNA","volume":"8","author":"Rui","year":"2022","journal-title":"Sci.\nAdv."},{"issue":"2","key":"2026092216092271100_cit65","doi-asserted-by":"publisher","first-page":"102486","DOI":"10.1016\/j.omtn.2025.102486","article-title":"In vivo base editing\nof Angptl3 via lipid nanoparticles to treat cardiovascular disease","volume":"36","author":"Khirallah","year":"2025","journal-title":"Mol. Ther.--Nucleic Acids"}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.6c10855","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/37\/25642\/68436381\/acsnano.6c10855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/20\/37\/25642\/68436381\/acsnano.6c10855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:09:29Z","timestamp":1790107769000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/20\/37\/25642\/5425733\/Boosting-Ligand-Mediated-Hepatic-mRNA-Delivery-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":65,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2026,9,8]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.6c10855","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}